WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems

Overview of attention for article published in Drug Safety, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 1 X user

Citations

dimensions_citation: 167 Dimensions

Readers on

mendeley: 298 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 11 policy documents that reference this research output.

Safety monitoring of molnupiravir for treatment of mild to moderate COVID-19 infection in low and middle-income countries using cohort event monitoring: a WHO study, 11 March 2022

Cited by World Health Organization on 11 Mar 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Protocol template to be used as template for observational study protocols: cohort event monitoring (‎CEM)‎ for safety signal detection after vaccination with COVID-19 vaccines

Cited by World Health Organization on 01 Jul 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Safety of medicines: the WHO collaborating centre for international drug monitoring

Cited by World Health Organization on 18 Feb 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO Drug Information 2016, vol. 30, 1 [‎full issue]‎

Cited by World Health Organization on 18 Feb 2020

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

OMS indicadores de farmacovigilancia: un manual práctico para la evaluación de los sistemas de farmacovigilancia

Cited by World Health Organization on 12 Jul 2019

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Indicateurs de l’OMS pour la pharmacovigilance : un manuel pratique pour l’évaluation des systèmes de pharmacovigilance

Cited by World Health Organization on 12 Mar 2019

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO Expert Committee on Biological Standardization 1011

Cited by Ministry of Health Knowledge Management Portal on 20 Sep 2018

The Knowledge Management Portal is an online resource that integrates health and health related information resources from the Ministry of Health and beyond, to provide a single point of access to valuable information that facilitates evidence based decision making.

WHO Expert Committee on Biological Standardization: sixty-eighth report

Cited by World Health Organization on 11 Jun 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone

Cited by World Health Organization on 26 Mar 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO pharmaceuticals newsletter: 2015, No. 3

Cited by World Health Organization on 18 May 2017

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems

Cited by World Health Organization on 01 Oct 2015

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.